Page last updated: 2024-08-17

lysine and Acute Relapsing Multiple Sclerosis

lysine has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benedict, RH; Bistulfi, GL; Chadha, K; Hennies, C; Kazim, L; Leung, C; Munschauer, F; Sternberg, D; Sternberg, Z; Weinstock-Guttman, B	1
Bozhinov, A; Daskalovska, V; Genov, K; Handzhiyski, Y; Ivanov, I; Mironova, R; Niwa, T	1

Other Studies

2 other study(ies) available for lysine and Acute Relapsing Multiple Sclerosis

Article	Year
Plasma pentosidine: a potential biomarker in the management of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:2 Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Inflammation Mediators; Linear Models; Lysine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; New York; Predictive Value of Tests; Recurrence; Severity of Illness Index; Spectrometry, Fluorescence; Time Factors; Treatment Outcome; Up-Regulation	2011
Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals. The Journal of allergy and clinical immunology, 2012, Volume: 129, Issue:3 Topics: Adult; Animals; Antibodies, Neutralizing; CHO Cells; Cricetinae; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Female; Glycation End Products, Advanced; Glycosylation; Haptens; Humans; Imidazoles; Immunotherapy; Interferon-beta; Lysine; Male; Multiple Sclerosis, Relapsing-Remitting; Protein Processing, Post-Translational; Recombinant Proteins	2012

Article

Year

Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:2

Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Inflammation Mediators; Linear Models; Lysine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; New York; Predictive Value of Tests; Recurrence; Severity of Illness Index; Spectrometry, Fluorescence; Time Factors; Treatment Outcome; Up-Regulation

2011

Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals.

The Journal of allergy and clinical immunology, 2012, Volume: 129, Issue:3

Topics: Adult; Animals; Antibodies, Neutralizing; CHO Cells; Cricetinae; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Female; Glycation End Products, Advanced; Glycosylation; Haptens; Humans; Imidazoles; Immunotherapy; Interferon-beta; Lysine; Male; Multiple Sclerosis, Relapsing-Remitting; Protein Processing, Post-Translational; Recombinant Proteins

2012